Goldman AM Sees Strong Buyout Opportunities in Japan, South Korea and Australia 
Nvidia Invests $500M in Firmus Technologies Ahead of Planned ASX IPO 
Wolfspeed Sues Navitas Over GaN and SiC Patent Infringement 
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal 
Bernstein Names IAG, Ryanair as Top European Airline Stocks Ahead of Earnings 
Chinese Chip Stocks Jump as Apple Reportedly Tests CXMT Memory Chips for China Devices 
Telenor to Buy Controlling Stake in Bahnhof in $630 Million Broadband Deal 
Zhipu AI Raises HK$31.37 Billion in Discounted Share Sale to Accelerate AI Growth 
Oil and LNG Tankers Turn Back as Strait of Hormuz Security Risks Escalate 
SK Hynix’s $28B U.S. IPO Draws Strong Demand as AI Chip Boom Fuels Investor Interest 
Netflix, Disney, YouTube Eye FIFA World Cup TV Rights in Multi-Billion Dollar Battle 
Shell Raises Q2 Upstream Outlook, Flags Qatar Gas Hit as Shares Rise 
Bain Capital Exits Kioxia After AI-Fueled Valuation Surge 
TetherMax Rebranding Highlights Official Exchange Partnerships and Transparent Operations 
Apple Tests China's CXMT Memory Chips as DRAM Maker Gains Global Market Share 
OpenAI GPT-5.6 Set for Wider Release After U.S. Commerce Approval, Report Says 
Japan Regional Bank Stocks Drop After Zentoshin Bankruptcy Sparks Credit Risk Concerns 
 - EconoTimes)
Dublin, May 08, 2018 -- The "Point-of-Care Diagnostics & Biosensors Europe 2018" conference has been added to ResearchAndMarkets.com's offering.
Point-of-Care Diagnostics Europe 2018 brings together the key opinion leaders from both academia and industry, this annual conference will discuss the expanding Point-of-Care Diagnostics and Global Health fields and provide the most up-to-date presentations from leaders in these fields and offer networking and engagement opportunities with delegates from around the world.
This conference will provide an overview of the point-of-care (POC) testing landscape, from novel technologies to regulatory approval. Experts in these fields will share their views on point-of-care in the clinical setting. The aim of this meeting is to bring together life science researchers that work at the interface between biology and chemistry and technology development to discuss problems, highlight solutions and facilitating collaborations. Also, we frame the role of POC testing in the expanding Global Health field and highlight opportunities existing in many parts of the world.
This conference covers POC Detection, POC Diagnostics and POC-based Treatment Options as part of the Comprehensive Coverage of this Expanding Field. The POC testing field is expanding focused not only on infectious disease diagnostics (which represents 80% of the marketplace) but also with cancer and cardiovascular disease focus. We address each of these segments in this conference.
Agenda:
- Impact of Microfluidics/Lab-on-a-Chip Technologies for Point-of-Care (POC) Diagnostics Applications
- Low Cost POC Diagnostics Platforms for Deployment Worldwide
- POC Diagnostics for Global Health: A Worldwide Perspective
- POC Diagnostics in Cardiovascular Disease Testing
- Point-of-Care Diagnostics in Infectious Disease Testing
- Wearable and Implantable Devices
- Worldwide Regulatory Trends and Hurdles in the Deployment of POC Testing
For more information about this conference visit https://www.researchandmarkets.com/research/nqcksd/european?w=12
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Biotechnology, Point-of-Care Diagnostics
